Literature DB >> 29627441

Amentoflavone-induced oxidative stress activates NF-E2-related factor 2 via the p38 MAP kinase-AKT pathway in human keratinocytes.

Lilik Duwi Wahyudi1, Jiwon Jeong1, Heejung Yang2, Jung-Hwan Kim3.   

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a key transcription factor that responds to oxidative stress and xenobiotics. Multiple lines of evidence suggest that Nrf2 activation protects against aging, inflammation, and many diseases, including cancer. Nrf2 activators derived from natural sources have been widely studied. In this study, we investigated the effect of amentoflavone (AFN), a biflavonoid found in many plants, on Nrf2 signaling in human keratinocytes (HaCaT cells). AFN significantly increased ARE luciferase activity by Nrf2 accumulation in the nucleus. Subsequently, the levels of a Nrf2 target protein, NQO-1, were significantly increased by AFN in a dose- and time-dependent manner. To verify the mechanism of AFN-induced activation of Nrf2 signaling, we measured generation of reactive oxygen species (ROS). Interestingly AFN triggered mild ROS production. Additionally, AFN-induced Nrf2 activation was inhibited by N-acetyl cysteine. Therefore, we studied the effect of ROS-related signaling on Nrf2 by measuring the activation of AKT and members of the mitogen-activated protein kinase family, such as extracellular signal-regulated kinase (ERK1/2) and p38. The results showed that the pharmacological inhibitor of PI3K/AKT (LY294002) or p38 (SB 203580), but not ERK1/2 (U0126), abrogated AFN-induced Nrf2 activation. Subsequently, we found that silencing or inhibition of p38 resulted in decrease of AKT phosphorylation as well as inhibition of Nrf2 accumulation. Furthermore, we found that AFN stabilized Nrf2 by inhibiting its ubiquitination. Taken together, our results suggest that AFN contributes to Nrf2 activation through ROS-mediated activation of the p38-AKT pathway in HaCaT cells.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AKT; Amentoflavone; Nrf2; ROS; p38

Mesh:

Substances:

Year:  2018        PMID: 29627441     DOI: 10.1016/j.biocel.2018.04.006

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

Review 1.  The Current Status of the Pharmaceutical Potential of Juniperus L. Metabolites.

Authors:  Wilson R Tavares; Ana M L Seca
Journal:  Medicines (Basel)       Date:  2018-07-31

2.  Amentoflavone as an Ally in the Treatment of Cutaneous Leishmaniasis: Analysis of Its Antioxidant/Prooxidant Mechanisms.

Authors:  Yasmin Silva Rizk; Sandy Santos-Pereira; Luiza Gervazoni; Daiana de Jesus Hardoim; Flávia de Oliveira Cardoso; Celeste da Silva Freitas de Souza; Marcelo Pelajo-Machado; Carlos Alexandre Carollo; Carla Cardozo Pinto de Arruda; Elmo Eduardo Almeida-Amaral; Tânia Zaverucha-do-Valle; Kátia da Silva Calabrese
Journal:  Front Cell Infect Microbiol       Date:  2021-02-25       Impact factor: 5.293

Review 3.  Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid.

Authors:  Xifeng Xiong; Nan Tang; Xudong Lai; Jinli Zhang; Weilun Wen; Xiaojian Li; Aiguo Li; Yanhua Wu; Zhihe Liu
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

4.  Medicarpin Increases Antioxidant Genes by Inducing NRF2 Transcriptional Level in HeLa Cells.

Authors:  Jung-Hwan Kim; Dong-Min Kang; Young-Jin Cho; Jin-Won Hyun; Mi-Jeong Ahn
Journal:  Antioxidants (Basel)       Date:  2022-02-18

5.  Amentoflavone Ameliorates Carrageenan-Induced Pleurisy and Lung Injury by Inhibiting the NF-κB/STAT3 Pathways via Nrf2 Activation.

Authors:  Tianhua Hou; Manshi Yang; Kun Yan; Xiaoye Fan; Xinxin Ci; Liping Peng
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

6.  2-Methoxy-7-Acetonyljuglone Isolated from Reynoutria japonica Increases the Activity of Nuclear Factor Erythroid 2-Related Factor-2 through Inhibition of Ubiquitin Degradation in HeLa Cells.

Authors:  Jung-Hwan Kim; Atif Ali Khan Khalil; Hye-Jin Kim; Sung-Eun Kim; Mi-Jeong Ahn
Journal:  Antioxidants (Basel)       Date:  2019-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.